Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

deltaDOT Announces Manufacturer for 1D Protein/Nucleic Acid Analysis System

Published: Thursday, September 08, 2005
Last Updated: Thursday, September 08, 2005
Bookmark and Share
The Peregrine Protein/Nucleic Acid analysis system and the Merlin DNA sequencer are designed to offer unrivalled sensitivity, ultra high-speed throughput and low running costs.

deltaDOT has announced that Lathrop Engineering has been awarded the manufacturing contract for its first two commercial products, a protein/nucleic acid analysis system and a DNA sequencer. These products are based on deltaDOT's proprietary Label Free Intrinsic Imaging (LFII) technology.

Both the Peregrine Protein/Nucleic Acid analysis system and the Merlin DNA sequencer are designed to offer unrivalled sensitivity, ultra high-speed throughput and low running costs.

Tony Baxter, CEO of deltaDOT said "We are very impressed with Lathrop's manufacturing capabilities and are confident in their ability to deliver high-quality systems with fast delivery times.”

He adds, “Having previously developed a range of biomedical products, including electrophoresis systems, Lathrop understands the stringent tolerances of this business and the requirements of manufacturing precision instrumentation.”

Further he said, “Their technical abilities, industry experience, and short development cycles are all advantages that we can pass on directly to our customers."

deltaDOT's biomolecule detection technique, LFII, is derived from recent innovations in high-energy physics research and their application in modern biochemical analysis.

Unlike conventional techniques, the technology does not require target molecules to be labelled and therefore enables superior data quantification, while reducing throughput times, operating costs and health and safety issues.

"Both the management and engineering teams at Lathrop are tremendously excited to be working with deltaDOT on the Peregrine and Merlin projects," said Bruce Richardson, VP of Engineering for Lathrop.
He adds, "Founded in their background and field knowledge, both in the bioscience and particle physics, deltaDOT has created a core set of technologies that offer immediately recognizable benefits.”

“The ability to detect and quantify unlabelled proteins is a significant accomplishment and immensely important to the research and pharmaceutical development communities.”

Further he said, “This will also provide deltaDOT with a substantial competitive advantage in the biomedical market and we look forward to sharing in their future success."

 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Genetic Links to Brain Cancer Cell Growth
Researchers discover clues to tumour behaviour from genetic differences between brain cancer cells and normal tissue cells.
Unexpected Role for Epigenetic Enzymes in Cancer
Researchers use epigenetics to identify the role of an enzyme family as regulators of genetic message interpretation in yeast.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
Tissue Damage Is Key for Cell Reprogramming
Researchers have shown tissue damage is important for cells to return to an embryonic state for cell reprogramming.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
New Form of Autism Found
An international team of researchers have identified a new form of syndromic autism.
Accelerating the Detection of Foodborne Bacterial Outbreaks
The speed of diagnosis of foodborne bacterial outbreaks could be improved by a new technique developed by researchers at the Georgia Institute of Technology.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!